Skip to main content
SIBN logo
SIBN
(NASDAQ)
SI-BONE, Inc.
$15.95-- (--)
Loading... - Market loading

SI-BONE (SIBN) Company Profile

Complete business overview, executive team, trading details, and corporate information.

SI-BONE, Inc.
SIBNNasdaq Stock MarketHealthcareMedical Devices

About SI-BONE

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Company Information

CEOLaura Francis
Founded2008
IPO DateOctober 17, 2018
Employees376
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone408 207 0700
Address
471 El Camino Real, Suite 101 Santa Clara, California 95050 United States

Corporate Identifiers

CIK0001459839
CUSIP825704109
ISINUS8257041090
EIN26-2216351
SIC3841

Leadership Team & Key Executives

Laura A. Francis MBA
Chief Executive Officer and Director
Jeffrey W. Dunn
Executive Chairman
Anshul Maheshwari
Chief Operating Officer and Chief Financial Officer
Michael A. Pisetsky J.D.
Chief Business and Legal Affairs Officer, Secretary and General Counsel
Anthony J. Recupero
Advisor
Dr. Scott A. Yerby Ph.D.
Senior Vice President of Engineering and Chief Technology Officer
Saqib Iqbal
Vice President of Financial Planning and Analysis and Investor Relations
Ian Bailey
Vice President of Product and Marketing
Dr. Daniel Joseph Cher M.D.
Senior Vice President of Clinical, Regulatory Affairs and Quality
Dr. W. Carlton Reckling M.D.
Chief Medical Officer and Vice President of Medical Affairs